Open original FDA record ↗Recall record
- FDA identifier
- Z-0776-2025
- Company in FDA record
- Baxter Healthcare Corporation
- FDA classification date
- Dec 27, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Devices were identified as released after repair without full testing being performed, which includes flow testing.
Source facts
- Action
- Customers were contacted via telephone beginning 11/19/24. Baxter Healthcare is calling to notify you of a potential issue with the Spectrum infusion pump. One of your devices has been identified as released after repair without full testing being performed, which includes flow testing. Baxter is requesting the return of the impacted infusion pump to perform all tests required and confirm that the infusion pump performs as expected. As part of this process, we need to make you aware of the potential hazard associated with flow related issues. Flow issues may cause excessive therapy, free-flow condition, insufficient therapy or interruption of therapy. These may lead to serious adverse health consequences, including permanent injury and death. Send signed form to Global CORP Service Quality Field Actions Global_CORP_Service_Quality_Field_Actions@baxter.com
- Initiated
- 2024-11-19
- Root cause
- Process control
- Distribution
- US Nationwide distribution in the states of AL, IN.
- Recall number
- Z-0776-2025
- Recall status
- Open, Classified
- CDRH record ID
- 211364
- FDA classified
- 2024-12-27
- Recall event number
- 95848